Yuki Gosei Kogyo Co., Ltd. (TYO:4531)

Market Cap	10.60B
Revenue (ttm)	15.75B
Net Income (ttm)	695.00M
Shares Out	21.54M
EPS (ttm)	32.25
PE Ratio	15.26
Forward PE	n/a
Dividend	10.00 (2.20%)
Ex-Dividend Date	Mar 30, 2026

Volume	1,550,700
Average Volume	629,880
Open	465.00
Previous Close	475.00
Day's Range	439.00 - 510.00
52-Week Range	214.00 - 640.00
Beta	0.30
RSI	68.64
Earnings Date	Jan 30, 2026

About Yuki Gosei Kogyo

Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, nicotinamide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufactur...

• Industry: Chemicals
• Sector: Materials
• Founded: 1947
• Employees: 296
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4531

Financial Performance

In 2024, Yuki Gosei Kogyo's revenue was 15.13 billion, an increase of 16.98% compared to the previous year's 12.93 billion. Earnings were 896.00 million, an increase of 15.46%.